Category: General Surgery

Interactive model enhances pancreas segmentation accuracy in CT images

A novel deep-learning network, RRM-TransUNet, significantly improves pancreas segmentation accuracy in CT images. Achieving a dice similarity coefficient of 93.82% and an average symmetric surface distance error of 1.12 mm on multiple datasets, this model integrates clinical expertise with user interaction. By using advanced techniques like rotary position embedding and a mixture of experts mechanism, […]

Microwave ablation matches surgical resection for liver metastases

In a cohort study involving 1,027 patients with colorectal liver oligometastases, survival outcomes between microwave ablation (MWA) and surgical resection (SR) were compared. After a median follow-up of 39.8 months, no significant differences were found in overall survival rates (MWA: 70.6 months vs. SR: 83.2 months) or progression-free survival (MWA: 18.5 months vs. SR: 22.3 […]

Artificial intelligence enhances precision and safety in surgery

The integration of artificial intelligence (AI) in surgical medicine is revolutionizing the field, enhancing the precision and safety of procedures. AI aids in preoperative diagnosis, real-time navigation during surgery, and postoperative management. Specific case studies demonstrate significant improvements in surgical outcomes, such as reduced complications and faster recoveries. However, challenges including cost, data security, and […]

Arterial resection improves survival in pancreatic cancer patients.

A comparative analysis of 203 pancreatic cancer patients between 2010-2015 and 2016-2021 revealed significant improvements in outcomes due to multidisciplinary treatment. Patients in the latter group had higher preoperative chemotherapy rates (95%) and lower morbidity and pancreatic fistula rates. Overall survival notably improved, from 26.0 to 48.2 months, emphasizing the efficacy of radical resection, including […]

Successful implementation of enhanced recovery programs identified through contextual factors

A study identifies critical contextual factors for effective implementation of enhanced recovery programs (ERPs) in hospitals. Out of 86 hospitals, 30.2% achieved high ERP adherence. Success scenarios included low-socioeconomic status hospitals eager for change lacking team cohesion, low surgical volume hospitals with strong staff buy-in, and high-volume hospitals needing leadership support while ensuring appropriate workload. […]

Neoadjuvant chemotherapy improves survival in resectable pancreatic cancer.

Neoadjuvant chemotherapy using gemcitabine and S-1 significantly outperforms upfront surgery for patients with resectable pancreatic ductal adenocarcinoma (PDAC). In a randomized trial with 364 participants, median overall survival was 37.0 months for the chemotherapy group compared to 26.6 months for the surgery group, with a hazard ratio of 0.73. Additionally, median relapse-free survival was extended […]

Effective Implementation Strategies for Shared Decision-Making Identified

The systematic review reveals that implementing shared decision-making (SDM) in gastrointestinal cancer care faces challenges despite its importance for patient autonomy. Researchers synthesized data from 37 qualitative studies, identifying nine influencing factors categorized into two subthemes. Key strategies include enhancing medical staff’s understanding of patients’ needs and improving communication skills to facilitate SDM. These findings […]

AI Model Outperforms Clinicians in Tumor Differentiation

An artificial intelligence model employing endoscopic ultrasonography (EUS) has demonstrated effective differentiation between small gastric stromal tumors (GSTs) and gastric leiomyomas (GLs). Utilizing a dataset of 358 EUS images, the ResNet50 architecture achieved impressive area under the curve (AUC) values of 0.994 and 0.911 for micro and small tumors respectively. In comparison, clinicians and clinical […]

Idarubicin surpasses gemcitabine and cisplatin in effectiveness.

In a study investigating treatment options for unresectable intrahepatic cholangiocarcinoma (ICCA), idarubicin exhibited the highest cytotoxicity among ten tested drugs, greatly outperforming the standard gemcitabine and cisplatin combination. Tumor growth was significantly inhibited in mouse models treated with idarubicin and gemcis, with pronounced effects particularly noted on days 12 and 15. Preliminary clinical findings also […]

New method predicts survival in borderline pancreatic cancer

Carbohydrate antigen 19-9 (CA19-9) evaluation through a novel method significantly predicts overall and disease-free survival in borderline resectable pancreatic adenocarcinoma patients undergoing neoadjuvant therapy. A study with 991 participants revealed that those with a mean Δf below defined thresholds demonstrated significantly improved prognoses, associating with hazard ratios for overall survival of 0.6 and 0.4 for […]